229: Nobels for science, biotech dealmaking, & a friendly FTC

Published: Oct. 6, 2022, 5:41 p.m.

b'The newest Nobel laureates got their phone calls from Stockholm this week, and STAT science writer Megan Molteni joins us to explain their prize-winning work in medicine and chemistry. We also discuss the latest news in the life sciences, including the state of biotech dealmaking and the evolution of Amylyx Pharmaceuticals.'